Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients’ lives and how best to manage these events?

Credit available for this activity expires: 11/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998369?ecd=bdc_podcast_libsyn_mscpedu